Cilapen 500 500 mg. Powder for injection
PDF Leaflet Revision Date: 13 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of infections caused by susceptible bacteria.
Dosage (summary)
1-2 g daily in divided doses; adjust for renal function.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; use with caution in breastfeeding.
Key Drug Interactions
- Valproic acid
- Warfarin
- Ganciclovir
Contraindications
- Hypersensitivity to carbapenems
- Meningitis
Common side effects
- Nausea
- Diarrhea
- Seizures
- Rash
Counselling Points
- Report any allergic reactions
- Avoid use in pregnancy
- Monitor for CNS effects
Serious warnings
- Risk of seizures in renal impairment
- Monitor hepatic function
Important Disclaimer
The Cilapen 500 500 mg. Powder for injection professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
